A Wolkin1, E Duncan, M Sanfilipo
1Psychiatry Service, New York VA Medical Center, New York.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Schizophrenia treatment resistance may stem from non-dopaminergic pathways. Reducing presynaptic dopamine activity (DA) with alpha-methylparatyrosine did not improve psychosis in non-responders, suggesting alternative mechanisms.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: